Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sonus Pharma (SNUS) ? Opinions -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Giller who wrote (262)	3/13/1998 6:50:00 PM
From: David S.	Respond to of 384

right

To: Mr. Giller who wrote (262)	3/14/1998 10:27:00 AM
From: nanoh	Read Replies (2) \| Respond to of 384

- they should assemble everything at the end of march or first few days of april. - then FDA will have 90 days to respond - usually the protocol of trials is agreed with the FDA before the trials even start - some time ago FDA lost a legal battle with SNUS this action looks really as a repay. - ABBOT will take much bigger role in trials. - there is no any evidence of any safety problems. - this stuff will be aproved and SNUS partner ABBOT is much powerfull then MOBI partner